These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30053824)

  • 1. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis.
    Kryštůfková O; Hulejová H; Mann HF; Pecha O; Půtová I; Ekholm L; Lundberg IE; Vencovský J
    Arthritis Res Ther; 2018 Jul; 20(1):158. PubMed ID: 30053824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The levels and clinical significance of serum B cell activating factor in Chinese patients with polymyositis or dermatomyositis].
    Peng QL; Xie Y; Zhang RF; Shu XM; Wang GC
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):210-3. PubMed ID: 22781895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
    Matsushita T; Kobayashi T; Kano M; Hamaguchi Y; Takehara K
    J Dermatol; 2019 Dec; 46(12):1190-1196. PubMed ID: 31631384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
    Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP
    Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.
    Kryštůfková O; Barbasso Helmers S; Venalis P; Malmström V; Lindroos E; Vencovský J; Lundberg IE
    Arthritis Res Ther; 2014 Oct; 16(5):454. PubMed ID: 25301447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis.
    Peng QL; Shu XM; Wang DX; Wang Y; Lu X; Wang GC
    Biomark Med; 2014; 8(3):395-403. PubMed ID: 24712431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
    Yamasaki Y; Yamada H; Nozaki T; Akaogi J; Nichols C; Lyons R; Loy AC; Chan EK; Reeves WH; Satoh M
    Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen.
    Nishikai M; Ohya K; Kosaka M; Akiya K; Tojo T
    Br J Rheumatol; 1998 Apr; 37(4):357-61. PubMed ID: 9619882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients.
    Hulejová H; Kryštůfková O; Mann H; Klein M; Pavlíčková K; Zámečník J; Vencovský J; Šenolt L
    Clin Exp Rheumatol; 2016; 34(2):222-9. PubMed ID: 26886056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis.
    Cruellas MG; Viana Vdos S; Levy-Neto M; Souza FH; Shinjo SK
    Clinics (Sao Paulo); 2013 Jul; 68(7):909-14. PubMed ID: 23917652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
    Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
    Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
    Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC
    Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum.
    Biswas T; Miller FW; Takagaki Y; Plotz PH
    J Immunol Methods; 1987 Apr; 98(2):243-8. PubMed ID: 3494784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis.
    Vázquez-Abad D; Rothfield NF
    Arthritis Rheum; 1996 Feb; 39(2):292-6. PubMed ID: 8849382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis.
    Hassan AB; Fathi M; Dastmalchi M; Lundberg IE; Padyukov L
    J Autoimmun; 2006 Aug; 27(1):62-8. PubMed ID: 16895750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.